Abstract
Proton NMR spectroscopy was applied to the assignment of the isomeric identity of commercially available chlorprothixene. Nuclear Overhauser effect studies confirmed that the clinically useful isomer is the cis (Z) configuration. An NMR method for determining the isomeric content of chlorprothixene was developed based on integration of the ratio of areas of signal strength of the cis-N-methyl in comparison to the trans-N-methyl resonances.
Similar content being viewed by others
REFERENCES
S. J. Enna, J. P. Bennett, D. R. Burt, I. Creese, D. U'Prichard, D. A. Greenberg, and S. H. Snyder. Nature 267:184 (1977).
L.-G. Allgen, B. Jonsson, B. Nauckhoff, M.-L. Andersen, I. Huus, and I. Moller Nielsen. Experientia 16:325 (1960).
I. Huus and A. Rauf Khan. Acta Pharmacol. Toxicol. 25:397–404 (1967).
J. E. Wallace. J. Pharm. Sci. 56:1437–1441 (1967).
S. P. Agarwal and M. I. Blake. J. Pharm. Pharmacol. 21:556 (1969).
H. Christensen. Acta Pharmacol. Toxicol. 34:16–26 (1974).
H. Oelschlager and R. Spohn. Arch. Pharm. 314:355–359 (1981).
J. Masse and A. Chauvet. Ann. Pharm. Franc. 41:579–589 (1983).
A. S. Horn, M. L. Post, and O. Kennard. J. Pharm. Pharmacol. 27:553–563 (1975).
A. Li Wan Po and W. J. Irwin. J. Pharm. Pharmacol. 32:25–29 (1980).
A. Li Wan Po and W. J. Irwin. J. Pharm. Pharmacol. 31:512–516 (1979).
E. Svatek. Ceskoslov. Farm. 14:332–334 (1965).
S. Tammilehto, M. Sysmalainen, and P. Makinen. J. Chromatogr. 285:235–241 (1984).
B. C. Rudy and B. Z. Senkowski. In K. Florey (ed.), Analytical Profiles of Drug Substances, Vol. 2, Academic Press, New York, 1973, pp. 63–84.
K.-H. A. Rosler. J. Chem. Ed. 63:1006 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosler, KH.A., Wright, J., Fox, K.M. et al. A Nuclear Magnetic Resonance (NMR) Method for the Determination of the cis/trans Isomeric Content of Chlorprothixene. Pharm Res 6, 706–708 (1989). https://doi.org/10.1023/A:1015942623581
Issue Date:
DOI: https://doi.org/10.1023/A:1015942623581